Back
NRX Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
NRXP
NRX Pharmaceuticals, Inc.
Last Price:
$2.38
Seasonality Move:
51.98%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NRXP is experiencing slight buying pressure.
NRX Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.2 | Buy |
| 20-day SMA: | 2.27 | Buy |
| 50-day SMA: | 2.58 | Sell |
| 200-day SMA: | 2.64 | Sell |
| 8-day EMA: | 2.27 | Buy |
| 20-day EMA: | 2.3 | Buy |
| 50-day EMA: | 2.49 | Sell |
| 200-day EMA: | 2.66 | Sell |
NRX Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 52.3 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.12 - 2.38) | Buy |
| Bollinger Bands (100): | (2.33 - 3.11) | Sell |
NRX Pharmaceuticals, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NRX Pharmaceuticals, Inc. Stock
Is NRX Pharmaceuticals, Inc. Stock a Buy?
-
NRX Pharmaceuticals, Inc. share price is 2.41 while NRXP 8-day simple moving average is 2.20, which is a Buy signal.
-
The stock price of NRXP is 2.41 while NRX Pharmaceuticals, Inc. 20-day SMA is 2.27, which makes it a Buy.
-
NRX Pharmaceuticals, Inc. 50-day simple moving average is 2.58 while NRXP share price is 2.41, making it a Sell technically.
-
NRXP stock price is 2.41 and NRX Pharmaceuticals, Inc. 200-day simple moving average is 2.64, creating a Sell signal.
NRXP Technical Analysis vs Fundamental Analysis
Sell
37
NRX Pharmaceuticals, Inc. (NRXP)
is a Sell
Is NRX Pharmaceuticals, Inc. a Buy or a Sell?
-
NRX Pharmaceuticals, Inc. stock is rated a SellThe current NRX Pharmaceuticals, Inc. [NRXP] share price is $2.41. The Score for NRXP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
NRX Pharmaceuticals, Inc. Stock Info
Market Cap:
67.7M
Price in USD:
2.41
Share Volume:
781.3K
NRX Pharmaceuticals, Inc. 52-Week Range
52-Week High:
6.01
52-Week Low:
1.40
Sell
37
NRX Pharmaceuticals, Inc. (NRXP)
is a Sell
NRX Pharmaceuticals, Inc. Share Price Forecast
-
What is the NRX Pharmaceuticals, Inc. stock price today?The NRX Pharmaceuticals, Inc. stock price is 2.41 USD today.
-
Will NRXP stock go up or go down?NRX Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is NRX Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NRX Pharmaceuticals, Inc. is overvalued.
Is NRX Pharmaceuticals, Inc. Stock a Buy?
-
NRX Pharmaceuticals, Inc. share price is 2.41 while NRXP 8-day exponential moving average is 2.27, which is a Buy signal.
-
The stock price of NRXP is 2.41 while NRX Pharmaceuticals, Inc. 20-day EMA is 2.30, which makes it a Buy.
-
NRX Pharmaceuticals, Inc. 50-day exponential moving average is 2.49 while NRXP share price is 2.41, making it a Sell technically.
-
NRXP stock price is 2.41 and NRX Pharmaceuticals, Inc. 200-day simple moving average is 2.66, creating a Sell signal.
Fundamental Analysis of NRX Pharmaceuticals, Inc.
Is NRX Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $1.58 per share.
Technical Analysis of NRX Pharmaceuticals, Inc.
Should I short NRX Pharmaceuticals, Inc. stock?
-
NRXP Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting NRX Pharmaceuticals, Inc. is a Sell
-
NRX Pharmaceuticals, Inc. Relative Strength Index (RSI) is 52.3, which suggest NRX Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for NRX Pharmaceuticals, Inc. is (2.12 - 2.38), which suggest NRX Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for NRX Pharmaceuticals, Inc. is (2.33 - 3.11), which suggest NRX Pharmaceuticals, Inc. is a Sell
* NRX Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.